CONFERENCES

      Joint Annual Convention of Philippines Societies of Atherosclerosis & Hypertension

      This annual convention is hosted by Philippine Society of Hypertension (PSH) in cooperation with the Philippine Society of Hypertension (PSH) Philippine Lipid and Atherosclerosis Society (PLAS) and aims to discuss the risk factors, diagnosis and management of hypertension, lipids, atherosclerosis and its complications, with topics ranging from strategies in risk reduction to optimal drug selection. The event is aimed at bringing together scientists, academics, researchers, healthcare professionals, regulators, and industry experts, and provides a forum for sharing knowledge and collaborating to identify new strategies for prevention, diagnosis, and management.

      26th PSH-PLAS Joint Annual Convention 2021

      Date

      Feb 17, 2021 - Feb 19, 2021

      Location

      Online

      This convention includes a plenary lecture by Dr. Gizelle Baker, director scientific engagement at PMI, addressing the holistic approach to risk reduction in recalcitrant smokers.

      See related presentations

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.